MEIOC
Basic information
Region (hg38): 17:44656404-44690308
Previous symbols: [ "C17orf104" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEIOC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 1 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 1 | 0 |
Variants in MEIOC
This is a list of pathogenic ClinVar variants found in the MEIOC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-44667697-A-C | not specified | Likely benign (Oct 05, 2021) | ||
17-44678875-C-T | not specified | Likely benign (Mar 01, 2023) | ||
17-44678927-C-G | not specified | Uncertain significance (Feb 10, 2022) | ||
17-44678945-T-C | not specified | Uncertain significance (May 27, 2022) | ||
17-44678945-T-G | not specified | Uncertain significance (Dec 16, 2023) | ||
17-44679001-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
17-44680599-A-G | not specified | Uncertain significance (Oct 03, 2022) | ||
17-44689569-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
17-44689629-G-A | not specified | Uncertain significance (Jun 17, 2022) | ||
17-44689642-C-T | not specified | Uncertain significance (May 05, 2023) | ||
17-44689698-C-T | not specified | Uncertain significance (Nov 13, 2023) | ||
17-44689707-T-G | not specified | Uncertain significance (Jan 03, 2024) | ||
17-44689722-G-T | not specified | Uncertain significance (Jun 05, 2023) | ||
17-44689723-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
17-44689725-A-G | not specified | Uncertain significance (Mar 31, 2024) | ||
17-44689729-C-G | not specified | Uncertain significance (Jan 05, 2022) | ||
17-44689734-A-T | not specified | Uncertain significance (Aug 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MEIOC | protein_coding | protein_coding | ENST00000409122 | 8 | 33915 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000332 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.83 | 362 | 474 | 0.764 | 0.0000231 | 6263 |
Missense in Polyphen | 79 | 138.52 | 0.57032 | 2014 | ||
Synonymous | 2.18 | 133 | 169 | 0.787 | 0.00000818 | 1776 |
Loss of Function | 5.50 | 0 | 35.3 | 0.00 | 0.00000171 | 507 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Is required for meiosis completion in both male and female germ cells. Confers stability to numerous meiotic mRNAs in gonads allowing proper initiation and progression into meiosis prophase I. The function may involve YTHDC2 and is independent of induction by retinoic acid (RA). Maintains an extended meiotic prophase I by properly promoting the transition from a mitotic to a meiotic cell cycle program by binding transcripts through its interaction with YTHDC2 that regulate the mitotic cell cycle. {ECO:0000250|UniProtKB:A2AG06}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.64
- rvis_percentile_EVS
- 84.05
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.435
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Meioc
- Phenotype
- reproductive system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- double-strand break repair;synaptonemal complex assembly;male meiosis I;female meiosis I;spermatid development;mRNA stabilization;oocyte development;metaphase plate congression;germline cell cycle switching, mitotic to meiotic cell cycle;chromosome organization involved in meiotic cell cycle
- Cellular component
- nucleus;cytoplasm
- Molecular function